Yueshuo Li
-
- Cancer, Hypoxia, and Metabolism 2
-
- Viral-associated cancers and disorders 8
-
- Immune Cell Function and Interaction 3
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Cytomegalovirus and herpesvirus research 3
-
- Ferroptosis and cancer prognosis 2
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Cell Death and Disease (2 papers)Theranostics (2 papers)Signal Transduction and Targeted Therapy (2 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Yueshuo Li
19 papers receiving 685 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 151
- Oncology 199
- Immunology 135
- Molecular Biology 414
- Pathology and Forensic Medicine 67
Countries citing papers authored by Yueshuo Li
This map shows the geographic impact of Yueshuo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueshuo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueshuo Li more than expected).
Fields of papers citing papers by Yueshuo Li
This network shows the impact of papers produced by Yueshuo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueshuo Li. The network helps show where Yueshuo Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yueshuo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 21 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 74 | |
| 10 | 2021 | 14 | |
| 11 | 2020 | 23 | |
| 12 | 2020 | 38 | |
| 13 | 2020 | 89 | |
| 14 | 2019 | 82 | |
| 15 | 2019 | 49 | |
| 16 | 2019 | 11 | |
| 17 | 2018 | 145 | |
| 18 | 2018 | 62 | |
| 19 | 2017 | 28 |
About Yueshuo Li
Yueshuo Li is a scholar working on Oncology, Cancer Research and Virology, having authored 19 papers that have together received 695 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (8 papers), RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (3 papers), Immune Cell Function and Interaction (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (151 citations), Oncology (199 citations) and Immunology (135 citations). Yueshuo Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Ya Cao, Ann M. Bode, Xiangjian Luo, Zheqiong Tan, Min Tang, Feng Shi, Jianmin Hu, Longlong Xie, Feng Shi and Lin Zhao. Their work appears in journals such as Cell Death and Disease, Theranostics, Signal Transduction and Targeted Therapy, Cancer Science and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.